Streptococcus pneumoniae interactions with the complement system.
Streptococcus pneumoniae interactions with the complement system.
复制标题
肺炎链球菌与补体系统的相互作用。
DOI:
10.3389/fcimb.2022.929483
复制
发表时间:
2022
影响因子:
5.7
通讯作者:
Brown, Jeremy S.
中科院分区:
文献类型:
--
作者:
Gil, Eliza;Noursadeghi, Mahdad;Brown, Jeremy S.
关键词:
Host innate and adaptive immunity to infection with Streptococcus pneumoniae is critically dependent on the complement system, demonstrated by the high incidence of invasive S. pneumoniae infection in people with inherited deficiency of complement components. The complement system is activated by S. pneumoniae through multiple mechanisms. The classical complement pathway is activated by recognition of S. pneumoniae by C-reactive protein, serum amyloid P, C1q, SIGN-R1, or natural or acquired antibody. Some S. pneumoniae strains are also recognised by ficolins to activate the mannose binding lectin (MBL) activation pathway. Complement activation is then amplified by the alternative complement pathway, which can also be activated by S. pneumoniae directly. Complement activation results in covalent linkage of the opsonic complement factors C3b and iC3b to the S. pneumoniae surface which promote phagocytic clearance, along with complement-mediated immune adherence to erythrocytes, thereby protecting against septicaemia. The role of complement for mucosal immunity to S. pneumoniae is less clear. Given the major role of complement in controlling infection with S. pneumoniae, it is perhaps unsurprising that S. pneumoniae has evolved multiple mechanisms of complement evasion, including the capsule, multiple surface proteins, and the toxin pneumolysin. There is considerable variation between S. pneumoniae capsular serotypes and genotypes with regards to sensitivity to complement which correlates with ability to cause invasive infections. However, at present we only have a limited understanding of the main mechanisms causing variations in complement sensitivity between S. pneumoniae strains and to non-pathogenic streptococci.
登录
查看更多内容
DOI:
10.1084/jem.20161621
发表时间:
2017-05-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Deniset JF;Surewaard BG;Lee WY;Kubes P
通讯作者:
Kubes P
影响因子:
3.1
作者:
Bogaert, Debby;Weinberger, Daniel;Malley, Richard
通讯作者:
Malley, Richard
影响因子:
30.3
作者:
Dalia AB;Weiser JN
通讯作者:
Weiser JN
影响因子:
30.3
作者:
Broadley, Steven P.;Plaumann, Ann;Verschoor, Admar
通讯作者:
Verschoor, Admar
DOI:
10.2174/187153008786848321
发表时间:
2008-12
期刊:
Endocrine, metabolic & immune disorders drug targets
影响因子:
--
作者:
Agrawal A;Suresh MV;Singh SK;Ferguson DA Jr
通讯作者:
Ferguson DA Jr